Intervention Protocol and Training Reduced Hospital Stay for Babies With NAS
May 5th 2015Published in the journal Pediatrics, the study found that the length of stay was reduced by 50% following staff training in the assessment of symptoms of neonatal abstinence syndrome along with implementation of standardized intervention protocols.
Read More
The Clinical Core of the JNC 8 Hypertension Guidelines
May 4th 2015The latest Joint National Committee guidelines are based on 27 large clinical trials concerning hypertension management. These trials are often discussed in isolation, but their data have never been aggregated into a single source.
Read More
Hospital Use of Skilled Nursing Facilities Linked to Mortality, Spending
May 4th 2015Patients at hospitals with high rates of skilled nursing facility discharge usually have poorer outcomes and higher downstream spending, according to researchers from Massachusetts Institute of Technology and Vanderbilt University.
Read More
State Enrollment Exchanges Struggling Financially
May 4th 2015Nearly half of the 17 insurance marketplaces set up by the states and the District under President Obama's health law are struggling financially. Many of the online exchanges are wrestling with surging costs and tepid enrollment numbers.
Read More
The Emerging Role of Private Patient Advocates
May 4th 2015Private patient advocates work as private consultants for patients and help manage health needs. Services vary from attending doctor visits, researching medical treatments, helping with medical equipment purchases to handling insurance claims, disputing hospital bills, and scheduling appointments.
Read More
How Healthcare Innovation Centers Are Transforming Healthcare Delivery
May 3rd 2015Between November 2014 and January 2015, The Commonwealth Fund conducted an online survey of innovation centers affiliated with healthcare organizations to learn about their potential role in promoting health system transformation.
Read More
Speedy Drug Approvals Have Become the Rule, Not the Exception
May 2nd 2015A majority of recent drug development has been in therapies that qualify for at least one special approval pathway that Congress has passed over the past few decades for important drugs that treat life-threatening or rare diseases.
Read More
US Individual Insurance Market Grows 46% in First Year Under ACA, Study Finds
May 1st 2015In 2014, low- and moderate-income consumers were able to use premium subsidies to buy health coverage on Marketplaces under the Affordable Care Act. The individual health insurance market had been relatively flat for 3 years' prior.
Read More
Challenges With Including PROs in Oncology Product Labels
May 1st 2015The debate over including patient reported outcomes on oncology drug labels continues. The FDA expects well-defined and validated measurement tools and the patient community wants patient experiences to find their way to the label.
Read More
Express Scripts Eyeing Pricey Cancer Drugs Next
May 1st 2015Pharmacy benefit manager Express Scripts Holding Co, which has aggressively negotiated lower costs of new hepatitis C drugs, on Wednesday said a new "focus area" will be subduing costs of a growing wave of pricey biotech cancer drugs.
Read More
Study Finds Poor Quality Patient Outcomes Data in Clinical Registries
April 30th 2015A review of clinical registries determined data collection on patient outcomes are substandard and the information is not useful for patients, physicians, and policy makers, according to a paper published in the Journal for Healthcare Quality.
Read More
ADA, AMA, and YMCA Praise Introduction of Medicare Diabetes Prevention Act
April 30th 2015Today's call for Medicare to cover the Diabetes Prevention Program is part of a broader effort by advocacy groups and the AMA to identify those with prediabetes and intervene before people develop full-blown diabetes.
Read More
EHR Implementation Reduces Practice Productivity, Increases Reimbursement
April 30th 2015Although practices saw a decrease in patient visits during the 2 years after electronic health record implementation, they reported an increase in revenue during that same time period, according to a study in the Journal of the American Medical Informatics Association.
Read More
Independent Committee Recommends T-Vec for Approval Despite FDA Staff Concerns
April 30th 2015Amgen might be the latest entrant in the immunotherapy realm if the FDA heeds the advice of an independent advisory panel, recommending Amgen's anticancer viral therapy, T-Vec, for melanoma treatment.
Read More